Keywords: Myocardium, Spectroscopy
Myocardial fibrosis plays a key role in the pathological remodeling of the diseased heart. Yet, there is currently no routine screening method for it. The gold standard, histological examination, is highly invasive. Other alternatives are either costly (e.g. PET-CT, MRI) or subjective (echocardiography). Using HRMAS MRS, we analyzed blood samples from subjects diagnosed with common myocardial fibrosis (MF), amyloidosis (CA), or sarcoidosis (CS), plus controls. The identified regions of interest (ROI) and principal components (PC) enabled us to distinguish between diseased and not-diseased, and between the different disease groups. This may contribute to earlier diagnosis and increased success of treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords